It’s not out of the question that BOT’s resubmission could be a class 1, 2 month review.
Ann: FDA Confirms Approach to Sofdra NDA Resubmission, page-49
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
41.0¢ |
Change
-0.010(2.38%) |
Mkt cap ! $751.1M | |||
| Open | High | Low | Value | Volume |
| 41.5¢ | 42.5¢ | 41.0¢ | $949.4K | 2.280M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 745308 | 40.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 41.0¢ | 257734 | 11 |
View Market Depth
| Last trade - 12.14pm 05/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |